Pulmonary Embolism
Conditions
Keywords
pulmonary embolism, chronic thromboembolic pulmonary hypertension, mechanism, therapy, outcome
Brief summary
To explore the pathogenesis, therapy and outcome of pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH).
Detailed description
The study recruited consecutive outpatients or hospitalized patients diagnosed with pulmonary embolism (PE cohort) and chronic thromboembolic pulmonary hypertension (CTEPH cohort). The follow-up of all patients was performed annually by phone or outpatient visit. The main outcomes were bleeding, recurrent events, and survival. The objective of the study was to explore the pathogenesis, therapy and outcome of PE and CTEPH.
Interventions
None listed
Sponsors
China National Center for Cardiovascular Diseases
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All hospitalized patients or outpatients diagnosed with PE or CTEPH; * Age ≥18.
Exclusion criteria
* Refused informed consents.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recurrent Incidence of Patients | through study completion, an average of 1 year. | Recurrent PE was measured by computed tomography pulmonary angiography (CTPA) or ventilation/perfusion (V/Q) lung scans. Recurrent deep venous thrombosis was measured by lower extremity Doppler ultrasound. |
| Bleeding Rate of Patients | through study completion, an average of 1 year. | Events were recored by follow-up. |
| Survival Rate of Patients | through study completion, an average of 1 year. | Events were recored by follow-up. |
Outcome results
None listed